Price $185.95 |
Market Cap
14.84B
|
Sector Health Care |
Div. Growth
8.80%
|
|
P/E
36.0
|
P/B
4.22
|
P/S
4.89
|
Dividend %
0.90%
|
|
P/CF
842.9
|
P/FCF
57.3
|
Op. Cash Flow
615.3K
|
FCF
3.0
|
|
Op. Margin
18.00%
|
Net Margin
13.70%
|
ROE
12.20%
|
ROI
9.80%
|
|
ROA
7.70%
|
EPS Growth
28.60%
|
Current Ratio
2.4
|
Debt/Equity
33.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| CytomX Therapeutics Inc (CTMX) | $6.57 | - | - | 319.2M | Strong Buy |
| Kindred Biosciences Inc (KIN) | $4.03 | - | - | 171.6M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $9.48 | - | - | 10.2B | Strong Buy |
| Aerpio Pharmaceuticals Inc (ARPO) | $1.29 | - | - | 63.5M | Strong Buy |
| Capital Senior Living Corporat (CSU) | $0.59 | - | - | 20.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
